Breckenridge Pharmaceutical recalled nearly 360,000 bottles of duloxetine on June 4 after the FDA said the drug contained high levels of nitrosamines. The recall covers FDA duloxetine nitrosamine impurity concerns tied to delayed-release capsules sold nationwide.
Duloxetine is a generic version of Cymbalta, and the recall involves both 30-mg and 60-mg capsules. Patients with the recalled medicine were told to contact a doctor or pharmacist about next steps before making any change to treatment.
Breckenridge Pharmaceutical recall
The recalled product is duloxetine delayed-release capsules. Breckenridge Pharmaceutical acted on June 4, and the FDA said the reason was high levels of nitrosamines, a chemical compound that may increase the risk of cancer.
The scale is large enough to affect routine pharmacy stock and home medicine cabinets at the same time. Nearly 360,000 bottles were pulled, which means the recall is not limited to a single local supply chain or one isolated batch.
30-mg lot code 241180C
The clearest lot information released so far applies to the 30-mg capsules. Those bottles carry lot code 241180C and an expiration date of April 2027.
Breckenridge Pharmaceutical also included 60-mg capsules in the recall, but the lot information released in the facts here identifies only the 30-mg product. That leaves patients with 60-mg capsules needing to check whether their bottle matches the recall notice rather than assuming it is unaffected.
Nationwide duloxetine distribution
The medication was distributed nationwide, so the recall reaches patients well beyond a single region. Anyone with duloxetine delayed-release capsules should look at the strength on the label, then compare the bottle details against the recalled 30-mg lot code if that is the strength in hand.
The FDA’s instruction is practical rather than ambiguous: people with the recalled medication should speak with a doctor or pharmacist about what to do next. Patients should not change treatment on their own just because the product was withdrawn, since the medicine remains a prescription antidepressant and any switch should be handled through a clinician.
The unresolved issue is the same one that matters most to patients with 60-mg capsules: which lot codes and expiration dates are included. Until that information is matched against the bottle in hand, the safest step is to verify the label with a pharmacist before taking another dose.
